Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;14(1):76-80.
doi: 10.17476/jmbs.2025.14.1.76. Epub 2025 Apr 23.

Early Surgical Outcomes of Metabolic and Bariatric Surgery for Super Obesity in Korean Morbidly Obese Patients

Jin-Jo Kim  1
Affiliations

Early Surgical Outcomes of Metabolic and Bariatric Surgery for Super Obesity in Korean Morbidly Obese Patients

Jin-Jo Kim. J Metab Bariatr Surg. 2025 Apr.

Abstract

Purpose: To know about the feasibility and effectiveness of metabolic/bariatric surgery (MBS) in Korean super obese patients.

Materials and methods: We reviewed the medical records of 18 super obese (body mass index [BMI] ≥50 kg/m2) patients among 131 morbidly obese patients who underwent MBS at Incheon St. Mary's Hospital, the Catholic University of Korea from May 2011 to July 2024 and investigated the early surgical outcomes of these patients.

Results: Male/female ratio was 10 to 8, the mean age was 35.4±10.6 year, the mean body weight was 161.6±35.2 (range 112.9-241) kg, and the mean BMI was 58.3±8.2 (range 50.0-78.7) kg/m2. Sleeve gastrectomy (SG) was performed in 10 patients, SG plus procedure (SG+) in 5 patients, single anastomosis duodenoileal bypass with SG (SADI-S) in 2 patients and long biliopancreatic limb Roux-en-Y gastric bypass (LBPL RYGB) in 1 patient. The mean operation time was 170.3±64.5 minute and the mean postoperative hospital stay was 9±4.6 day. There was no postoperative morbidity and no mortality. The percentage of total weight loss at 1 year after surgery was 34.3±0.6% in SG, 23.1±3.2% in SG+, 45.8±4.5% in SADI-S and 47% in LBPL RYGB.

Conclusion: MBS was feasible and effective in Korean super obese patients. However, SG+ was less effective than expected in these patients.

Keywords: Bariatric surgery; Korea; Metabolic surgery; Morbid obesity; Super obesity.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None of the author has any conflict of interest.

Figures

Fig. 1
Fig. 1. The change in weight loss outcome. (A) Body weight change. (B) BMI change. (C) %TWL change.
RYGB = Roux-en-Y gastric bypass, SADI-S = single anastomosis duodenoileal bypass with sleeve gastrectomy, BMI = body mass index, %TWL = percentage of total weight loss.
See this image and copyright information in PMC

References

    1. Maroun J, Li M, Oyefule O, Badaoui JE, McKenzie T, Kendrick M, et al. Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI ≥ 50 kg/m2 . Surg Endosc. 2022;36:4946–4955. - PubMed
    1. Medas F, Moroni E, Deidda S, Zorcolo L, Restivo A, Canu GL, et al. The paradox of Zeno in bariatric surgery weight loss: superobese patients run faster than morbidly obese patients, but can’t overtake them. Front Surg. 2023;10:1100483. - PMC - PubMed
    1. Soong TC, Lee MH, Lee WJ, Almalki OM, Chen JC, Wu CC, et al. Long-term efficacy of bariatric surgery for the treatment of super-obesity: comparison of SG, RYGB, and OAGB. Obes Surg. 2021;31:3391–3399. - PubMed
    1. Parmar CD, Bryant C, Luque-de-Leon E, Peraglie C, Prasad A, Rheinwalt K, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m2: a systematic review comparing it with Roux-En-Y Gastric bypass and sleeve gastrectomy. Obes Surg. 2019;29:3039–3046. - PubMed
    1. Eskandaros MS, Abbass A. Standard biliopancreatic limb (50 cm) Roux-en-Y gastric bypass versus long biliopancreatic limb (100 cm) Roux-en-Y Gastric bypass in patients with body mass index 40-50 kg/m2: a randomized prospective study. Obes Surg. 2022;32:577–586. - PubMed